EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Investigation of the effects of chrysin on intestinal ischemia-reperfusion via apoptotic, oxidative stress, inflammation, and autophagy parameters

Ayşe Betül Öztürk, Nurhan Akaras, Hasan Şimşek, Fatih Mehmet Kandemir

Laboratuvar Hayvanları Bilimi ve Uygulamaları Dergisi · 2025

DOI: 10.62425/jlasp.1574905 ↗
AbstractBibliografische Angaben

Abstract

Aim: This study aimed to investigate chrysin's molecular, biochemical, and histological effects in an experimental intestinal ischemia/reperfusion (IR) model and to reveal possible protective mechanisms. Material-Methods: 35 Wistar rats were randomly divided into five groups: Control, CHR, IR, IR+CHR25, IR+CHR50. The IR model was established by inducing ischemia by ligating the superior mesenteric artery for one hour and restoring blood flow for two hours. In the study, MDA and GSH levels were analysed by manual biochemical method; SOD, CAT, GPx activities and NF-κB and NO levels by ELISA method; caspase-3, Beclin-1, LC3A, PERK, ATF-6 mRNA transcription levels by RT-PCR method. In addition, tissue structure was examined histologically. Results: MDA levels were doubled in the IR group and decreased with CHR (p< .05). In addition, CHR increased SOD, CAT, and GPx activities and GSH levels which decreased due to IR (p< .05). Inflammation markers NF-κB and NO were increased; and decreased with CHR (p< .05). Apoptosis marker caspase-3 increased in IR and decreased with CHR (p< .05). Autophagy markers Beclin-1 and LC3A were increased by CHR (p< .05); endoplasmic reticulum stress markers PERK and ATF-6 were increased in IR and decreased by CHR (p< .05). Severe histopathologic changes were observed in the IR and improved with CHR treatment. Conclusion: While IR causes damage to intestinal tissue, the antioxidant and anti-inflammatory properties of CHR have revealed its therapeutic potential against IR injury.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →